A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation

In people with suppressed HIV, including those with the M184V/I viral mutation, switching to combined bictegravir, emtricitabine, and tenofovir alafenamide has high efficacy, researchers report.Medscape Medical News

Source: Medscape Medical News Headlines - September 19, 2022 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news